|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910807955503321 |
|
|
Titolo |
HPV and other infectious agents in cancer : opportunities for prevention and public health / / Hans Krueger ... [et al.] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
New York, : Oxford University Press, 2010 |
|
|
|
|
|
|
|
ISBN |
|
0-19-045353-2 |
1-282-61353-7 |
9786612613531 |
0-19-977438-2 |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (560 p.) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Viral carcinogenesis |
Oncogenic viruses |
Papillomaviruses |
Papillomavirus diseases |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references and index. |
|
|
|
|
|
|
Nota di contenuto |
|
Contents; 1 Introduction-Infection and Cancer: An Expanding Paradigm; 2 Human Papillomavirus: Structure, Transmission, and Occurrence; 3 Human Papillomavirus: Infection, Natural History, and Carcinogenesis; 4 Human Papillomavirus: Associations with Cervical Cancer; 5 Human Papillomavirus: Associations with Noncervical Cancer; 6 Human Papillomavirus: Detection of Infection and Disease; 7 Human Papillomavirus: Prevention of Infection and Disease; 8 Hepatitis Viruses; 9 Helicobacter pylori; 10 Epstein-Barr Virus; 11 Human Herpesvirus Type 8; 12 Human T-cell Lymphotropic Virus Type 1 |
13 Conclusion-Infection and Cancer: A Paradigm ShiftIndex |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
After considering the aging population in developed countries, it has become clear to physicians and public policy administrators that prevention of cancer must play a more important role in national anti-cancer policy than it has in the past. The recent introduction of an HPV vaccine, coupled with discoveries concerning the relationship of H. pylori and cancer has brought the role of infectious agents in cancer into sharp focus in the medical community. While interest in the subject |
|
|
|
|